Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK.
Dr Al-Lamee studied at the University of Oxford and University College London and completed her training in clinical cardiology on the North West London Cardiology rotation in 2013, and completed her PhD at Imperial College London in 2018.
Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is lead author of the primary publication in The Lancet. Dr Al-Lamee has over 50 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career.